Milestone Pharmaceuticals (MIST) Receivables - Other (2018 - 2026)
Milestone Pharmaceuticals (MIST) reported Receivables - Other of $726,000 for Q2 2026, down 21.4% from $924,000 a year earlier and down 49.1% from the prior quarter.
Powered by 
Analysis
Milestone Pharmaceuticals (MIST) Receivables - Other (2018 - 2026) Analysis & Trends
At the end of FY2025, Milestone Pharmaceuticals posted Receivables - Other of $1.65 million, up 10.5% from FY2024.
- Receivables - Other has a five-year compound annual growth rate of 49.2% (FY2020 to FY2025).
- By year, Receivables - Other came in at $1.49 million in FY2024 (-53.6%), $3.21 million in FY2023 (+263.7%), $882,000 in FY2022 (+594.5%) and $127,000 in FY2021 (-43.0%).
- Five-year quarterly Receivables - Other spans a low of $89,000 in Q3 2021 and a high of $3.21 million in Q4 2023.
- Year over year, Receivables - Other gained in two of the last eight quarters, with an average decline of 20.7%.
- The high point for year-over-year Receivables - Other in five years was Q4 2022 (growth of 594.5%); the low point was Q4 2024 (a decline of 53.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.43 million (Q1 2026), $1.65 million (Q4 2025) and $700,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Milestone Pharmaceuticals | 82.17 Mn | -88.43 Mn | 527,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 726,000.00 |
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 924,000.00 |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 694,000.00 |
| Dec 31, 2022 | 882,000.00 |
| Sep 30, 2022 | 435,000.00 |
| Jun 30, 2022 | 261,000.00 |
| Mar 31, 2022 | 245,000.00 |
| Dec 31, 2021 | 127,000.00 |
| Sep 30, 2021 | 89,000.00 |
API Access
Milestone Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=MIST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "MIST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=MIST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();